LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 114

Search options

  1. Article ; Online: IKK-mediated CYLD phosphorylation and cellular redox activity.

    Erol, Adnan

    Molecular medicine (Cambridge, Mass.)

    2022  Volume 28, Issue 1, Page(s) 14

    Abstract: Oxidative stress is important in the development of obesity-related nephropathy (ORN). A causal relationship between IKK and ORN via CYLD-mediated inhibition of NRF2 has been described. However, contradictory explanations about the functioning of the ... ...

    Abstract Oxidative stress is important in the development of obesity-related nephropathy (ORN). A causal relationship between IKK and ORN via CYLD-mediated inhibition of NRF2 has been described. However, contradictory explanations about the functioning of the mechanisms that will be effective in the pathogenesis require clarification.
    MeSH term(s) I-kappa B Kinase/genetics ; I-kappa B Kinase/metabolism ; I-kappa B Kinase/pharmacology ; Oxidation-Reduction ; Oxidative Stress ; Phosphorylation ; Signal Transduction/drug effects
    Chemical Substances I-kappa B Kinase (EC 2.7.11.10)
    Language English
    Publishing date 2022-02-02
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 1283676-x
    ISSN 1528-3658 ; 1076-1551
    ISSN (online) 1528-3658
    ISSN 1076-1551
    DOI 10.1186/s10020-022-00439-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Importance of Efferocytosis in COVID-19 Mortality.

    Erol, Adnan

    Infection and drug resistance

    2022  Volume 15, Page(s) 995–1007

    Abstract: COVID-19 is a generally benign coronavirus disease that can spread rapidly, except for those with a group of risk factors. Since the pathogenesis responsible for the severity of the disease has not been clearly revealed, effective treatment alternatives ... ...

    Abstract COVID-19 is a generally benign coronavirus disease that can spread rapidly, except for those with a group of risk factors. Since the pathogenesis responsible for the severity of the disease has not been clearly revealed, effective treatment alternatives has not been developed. The hallmark of the SARS-CoV-2-infected cells is apoptosis. Apoptotic cells are cleared through a sterile process defined as efferocytosis by professional and nonprofessional phagocytic cells. The disease would be rapidly brought under control in the organism that can achieve effective efferocytosis, which is also a kind of innate immune response. In the risk group, the efferocytic process is defective. With the addition of the apoptotic cell load associated with SARS-COV-2 infection, failure to achieve efferocytosis of dying cells can initiate secondary necrosis, which is a highly destructive process. Uncontrolled inflammation and coagulation abnormalities caused by secondary necrosis reason in various organ failures, lung in particular, which are responsible for the poor prognosis. Following the short and simplified information, this opinion paper aims to present possible treatment options that can control the severity of COVID-19 by detailing the mechanisms that can cause defective efferocytosis.
    Language English
    Publishing date 2022-03-10
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2494856-1
    ISSN 1178-6973
    ISSN 1178-6973
    DOI 10.2147/IDR.S348639
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.

    Erol, Adnan

    Cancer management and research

    2022  Volume 14, Page(s) 2339–2356

    Abstract: Oxidative stress, which can cause DNA damage, can both activate TNF-R1 directly in the absence of TNF stimulation and phosphorylate c-Abl, thus promoting its cytoplasmic translocation. Persistent cytoplasmic localization of c-Abl has been associated with ...

    Abstract Oxidative stress, which can cause DNA damage, can both activate TNF-R1 directly in the absence of TNF stimulation and phosphorylate c-Abl, thus promoting its cytoplasmic translocation. Persistent cytoplasmic localization of c-Abl has been associated with cellular transformation. c-Abl phosphorylates OTULIN at tyrosine 56, thereby disrupting its relationship with LUBAC. OTULIN-released LUBAC interacts with SPATA2 and is recruited to the TNF-R1sc, facilitating SPATA2-CYLD interaction. All these interactions are required for the activation of IKKβ to stimulate NF-κB transcriptional activity following genotoxic stress. IKKβ also induces the critical phosphorylation of CYLD at serine 568 to increase its deubiquitinating (DUB) activity required for the termination of signaling cascades. Contrary to the widespread belief that CYLD is an absolute tumor suppressor, CYLD initiates and terminates NF-κB activity by alternately using its oncoprotein and tumor suppressor activities, respectively. If IKKβ fails to achieve the DUB activity-inducing phosphorylation at serine 568, CYLD would operate in a sustained mode of oncogenic activity. The resulting dysregulated NF-κB activation and other accompanying pathologies will disrupt cellular homeostasis in favor of transformation.
    Language English
    Publishing date 2022-08-05
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2508013-1
    ISSN 1179-1322
    ISSN 1179-1322
    DOI 10.2147/CMAR.S373557
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Are the emerging SARS-COV-2 mutations friend or foe?

    Erol, Adnan

    Immunology letters

    2021  Volume 230, Page(s) 63–64

    MeSH term(s) COVID-19/immunology ; COVID-19/virology ; Genetic Variation/physiology ; Humans ; Mutation ; RNA, Viral/genetics ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus/genetics ; United Kingdom ; Virus Replication/physiology
    Chemical Substances RNA, Viral ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2021-01-02
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 445150-8
    ISSN 1879-0542 ; 0165-2478
    ISSN (online) 1879-0542
    ISSN 0165-2478
    DOI 10.1016/j.imlet.2020.12.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis.

    Erol, Adnan

    Diabetes & metabolic syndrome

    2020  Volume 14, Issue 4, Page(s) 713–714

    Abstract: Background and aims: Older adults and people who have cardiovascular disorders (their common pathogenetic mechanism is progressive atherosclerosis) are at higher risk for severe illness from COVID-19 (coronavirus disease 2019). Their common pathogenetic ...

    Abstract Background and aims: Older adults and people who have cardiovascular disorders (their common pathogenetic mechanism is progressive atherosclerosis) are at higher risk for severe illness from COVID-19 (coronavirus disease 2019). Their common pathogenetic mechanism is progressive atherosclerosis in which oxLDL (oxidized LDL) plays major role. Receptor-mediated uptake of oxLDL by the monocyte-derived macrophages activates the long-term epigenetic reprogramming of innate immunity, which is termed "trained immunity." The aim of this work is to investigate the mechanisms and treatment possibilities that can control the activities of these specific macrophages.
    Methods: Search in Medline and PubMed relevant articles on the trained immunity and cytokine storm of COVID-19.
    Results and conclusions: When oxLDL-trained macrophages encounter SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in the lung, it causes unregulated cytokine secretion, leading to the alveolar damage. Therefore, blocking macrophage training by pioglitazone, a thiazolidinedione, could control the hyperactivation that the virus would trigger.
    MeSH term(s) Atherosclerosis/drug therapy ; Atherosclerosis/immunology ; Atherosclerosis/physiopathology ; Betacoronavirus/drug effects ; Betacoronavirus/immunology ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/drug therapy ; Coronavirus Infections/immunology ; Coronavirus Infections/physiopathology ; Humans ; Immunity, Innate ; Inflammation Mediators ; Lipoproteins, LDL/therapeutic use ; Macrophages/drug effects ; Macrophages/immunology ; Pandemics ; Pioglitazone/pharmacology ; Pioglitazone/therapeutic use ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/immunology ; Pneumonia, Viral/physiopathology ; SARS-CoV-2 ; Signal Transduction
    Chemical Substances Inflammation Mediators ; Lipoproteins, LDL ; oxidized low density lipoprotein ; Pioglitazone (X4OV71U42S)
    Keywords covid19
    Language English
    Publishing date 2020-05-12
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2273766-2
    ISSN 1878-0334 ; 1871-4021
    ISSN (online) 1878-0334
    ISSN 1871-4021
    DOI 10.1016/j.dsx.2020.05.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Role of oxidized LDL-induced “trained macrophages” in the pathogenesis of COVID-19 and benefits of pioglitazone

    Erol, Adnan

    Diabetes & Metabolic Syndrome: Clinical Research & Reviews

    A hypothesis

    2020  Volume 14, Issue 4, Page(s) 713–714

    Keywords Internal Medicine ; Endocrinology, Diabetes and Metabolism ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2273766-2
    ISSN 1878-0334 ; 1871-4021
    ISSN (online) 1878-0334
    ISSN 1871-4021
    DOI 10.1016/j.dsx.2020.05.007
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Book ; Online: High-dose intravenous vitamin C treatment for COVID-19

    Erol, Adnan

    2020  

    Abstract: COVID-19 pneumonia seems to be a lung injury caused by the hyperactivation immune effector cells. High-dose vitamin C may result in immunosuppression at the level of these effectors. Therefore, intravenous high-dose vitamin C could be safe and beneficial ...

    Abstract COVID-19 pneumonia seems to be a lung injury caused by the hyperactivation immune effector cells. High-dose vitamin C may result in immunosuppression at the level of these effectors. Therefore, intravenous high-dose vitamin C could be safe and beneficial choice of treatment in the early stages of COVID-19.
    Keywords covid19
    Publisher Center for Open Science
    Publishing country us
    Document type Book ; Online
    DOI 10.31219/osf.io/p7ex8
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Book ; Online: Pioglitazone treatment for the COVID-19-associated cytokine storm

    Erol, Adnan

    2020  

    Abstract: It has been determined that COVID-19 has a serious and often fatal course in elderly patients with diabetic and cardiovascular disease background. In this study, the causes of this relationship were investigated. It has been concluded that an anti- ... ...

    Abstract It has been determined that COVID-19 has a serious and often fatal course in elderly patients with diabetic and cardiovascular disease background. In this study, the causes of this relationship were investigated. It has been concluded that an anti-diabetic drug, pioglitazone, can be effective by directly modulating the pathogenetic mechanism.
    Keywords covid19
    Publisher Center for Open Science
    Publishing country us
    Document type Book ; Online
    DOI 10.31219/osf.io/avfpb
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis

    Erol, Adnan

    Diabetes Metab Syndr

    Abstract: BACKGROUND AND AIMS: Older adults and people who have cardiovascular disorders (their common pathogenetic mechanism is progressive atherosclerosis) are at higher risk for severe illness from COVID-19 (coronavirus disease 2019). Their common pathogenetic ... ...

    Abstract BACKGROUND AND AIMS: Older adults and people who have cardiovascular disorders (their common pathogenetic mechanism is progressive atherosclerosis) are at higher risk for severe illness from COVID-19 (coronavirus disease 2019). Their common pathogenetic mechanism is progressive atherosclerosis in which oxLDL (oxidized LDL) plays major role. Receptor-mediated uptake of oxLDL by the monocyte-derived macrophages activates the long-term epigenetic reprogramming of innate immunity, which is termed "trained immunity." The aim of this work is to investigate the mechanisms and treatment possibilities that can control the activities of these specific macrophages. METHODS: Search in Medline and PubMed relevant articles on the trained immunity and cytokine storm of COVID-19. RESULTS AND CONCLUSIONS: When oxLDL-trained macrophages encounter SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in the lung, it causes unregulated cytokine secretion, leading to the alveolar damage. Therefore, blocking macrophage training by pioglitazone, a thiazolidinedione, could control the hyperactivation that the virus would trigger.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #232513
    Database COVID19

    Kategorien

  10. Article ; Online: Type 2 diabetes and cancer as redox diseases?

    Erol, Adnan

    Lancet (London, England)

    2014  Volume 384, Issue 9946, Page(s) 853–854

    MeSH term(s) Diabetes Mellitus, Type 2/etiology ; Exercise/physiology ; Humans
    Language English
    Publishing date 2014-09-06
    Publishing country England
    Document type Comment ; Letter
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(14)61486-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top